Investisseurs
Icade’s Group Healthcare Property Investment Division 2022 combined financial statements are available on Icade's website.
The information presented in this section concerns both Icade Santé and Icade Healthcare Europe.
13 Mar 2023
Icade and Primonial REIM sign an exclusivity agreement for the acquisition of Icade's stake in Icade Santé
PDF - 257 Kb
7 Jul 2022
Icade Santé and Saint-Gobain Glass pioneer the use of low-carbon glass at Le Parc Polyclinic in Caen
PDF - 328 Kb
5 Jul 2022
Icade Santé adds to its portfolio in Spain and completes the sale of four healthcare facilities in France
PDF - 394 Kb
5 Apr 2022
18:10
New appointment at Icade Santé: Laurent Poinsard named General Secretary
PDF - 465 Kb
FINANCIAL RATINGS
LONG-TERM RATING | BBB |
SHORT-TERM RATING | A2 |
PERSPECTIVE | Stable |
SINCE | Mars 2023 |
Icade Santé est émetteur sur le marché obligataire en euro, source de diversification.
ISSUE | DEADLINE | CURRENCY | NOMINAL | COUPON | ISIN CODE | PROSPECTUS |
---|---|---|---|---|---|---|
10/25/2019 | 11/04/2029 | EUR | 500 000 000 | 0,875% | FR0013457967 | Download |
09/17/2020 | 09/17/2030 | EUR | 600 000 000 | 1,375% | FR0013535150 | Download |
25 Jul 2022
Combined Financial Statements H1 2022 - Healthcare Property Investment Division
PDF - 666 Kb
25 Jul 2022
Icade Santé - Condensed consolidated financial statements as of June 30, 2022
PDF - 560 Kb
26 Jul 2021
Condensed consolidated financial statements as of June 30, 2021
PDF - 1,3 Mb
Icade Santé, Places that care for people
Contact us